Inventor · disambiguated record
David Edward Clark
Also filed as: CLARK DAVID · CLARK DAVID E · CLARK DAVID EDWARD
29 granted patents·20 pending applications·217 citations·filing 2000–2025
96Inventor score
Files withASTERAND UK LTD10CHIESI FARM SPA8KALVISTA PHARMACEUTICALS LTD6ANTABIO SAS4AVENTIS PHARMA LTD4
Top patents by PatentIndex Score
49 records- 0192US6479519B1Substituted anilidesAVENTIS PHARMA LTD·Filed 2000·Granted Nov 12, 2002·72 cites·81 claims
- 0291US7326732B2EP2 receptor agonistsPHARMAGENE LAB LTD·Filed 2005·Granted Feb 5, 2008·18 cites·8 claims
- 0389US8207187B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2006·Granted Jun 26, 2012·20 cites·16 claims
- 0489US7803841B2EP2 receptor agonistsASTERAND UK LTD·Filed 2008·Granted Sep 28, 2010·11 cites·13 claims
- 0587US10493071B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsHELPERBY THERAPEUTICS LTD·Filed 2017·Granted Dec 3, 2019·7 cites·2 claims
- 0686US9694006B2Use of pyrroloquinoline compounds to kill clinically latent microorganismsBECK PETRA HELGA·Filed 2012·Granted Jul 4, 2017·12 cites·9 claims
- 0786US7662839B2EP2 receptor agonistsASTERAND UK LTD·Filed 2007·Granted Feb 16, 2010·7 cites·15 claims
- 0884US7528157B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2006·Granted May 5, 2009·3 cites·24 claims
- 0984US7507754B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2007·Granted Mar 24, 2009·3 cites·41 claims
- 1083US9266896B2Tricyclic compounds and methods of making and using sameCLARK DAVID·Filed 2011·Granted Feb 23, 2016·6 cites·18 claims
- 1182US6706738B2Substituted bicyclic heteroaryl compounds and their use as integrin antagonistsAVENTIS PHARMA LTD·Filed 2001·Granted Mar 16, 2004·20 cites·19 claims
- 1281US7196089B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Mar 27, 2007·8 cites·30 claims
- 1377US7417068B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 26, 2008·8 cites·15 claims
- 1476US11000511B2Chemical compounds as antibioticsANTABIO SAS·Filed 2018·Granted May 11, 2021·2 cites·38 claims
- 1575US7569602B2Furan derivatives as EP4 receptor antagonistsASTERAND UK LTD·Filed 2004·Granted Aug 4, 2009·6 cites·13 claims
- 1674US6562851B2Substituted bicyclic compoundsAVENTIS PHARMA LTD·Filed 2001·Granted May 13, 2003·8 cites·22 claims
- 1773US8080567B2EP2 receptor agonistsOXFORD ALEXANDER WILLIAM·Filed 2006·Granted Dec 20, 2011·2 cites·21 claims
- 1869US6593354B2Substituted benzoxazole compoundsAVENTIS PHARMA LTD·Filed 2001·Granted Jul 15, 2003·4 cites·24 claims
- 1969US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 2068US7858644B2EP4 receptor antagonistsASTERAND UK LTD·Filed 2009·Granted Dec 28, 2010·0 cites·23 claims
- 2164US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 2264US10954236B2Tyrosine amide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2019·Granted Mar 23, 2021·0 cites·15 claims
- 2361US2008306117A1Ep4 receptor antagonistsASTERAND UK LTD·Filed 2008·Application pending·0 cites
- 2459US12286411B2Indane derivatives for use in the treatment of bacterial infectionANTABIO SAS·Filed 2019·Granted Apr 29, 2025·0 cites·14 claims
- 2559US12247013B2Indane derivatives for use in the treatment of bacterial infectionANTABIO SAS·Filed 2019·Granted Mar 11, 2025·0 cites·40 claims
- 2659US12227475B2Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2022·Granted Feb 18, 2025·0 cites·21 claims
- 2757US2024092790A1Dihydrofuropyridine derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2857US2024092791A1Dihydrofuropyridine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2021·Application pending·0 cites
- 2955US2024391936A1Tetrahydrothieno pyridine derivatives as ddrs inhibitorsCHIESI FARM SPA·Filed 2022·Application pending·0 cites
- 3055US2024425453A1Isoindolines as pms2 inhibitorsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 3155US2024425483A1Indolines as protac compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 3254US10501461B2Tyrosine amide derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Dec 10, 2019·0 cites·14 claims
- 3354US2024059691A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3453US2024327412A1Factor xiia inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 3553US2024293392A1Inhibitor compoundsNEOPHORE LTD·Filed 2022·Application pending·0 cites
- 3652US2010261760A1EP2 Receptor AgonistsASTERAND UK LTD·Filed 2010·Application pending·0 cites
- 3751US2021284639A1Tyrosine amide derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 3851US2024016941A1Combination therapyANTABIO SAS·Filed 2021·Application pending·0 cites
- 3950US2025171400A1Aza-heterocyclyl carboxamide and related compounds and their use in treating medical conditionsX BIOTIX THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4048US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 4146US9839623B2Tricyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Granted Dec 12, 2017·0 cites·17 claims
- 4246US2022363668A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 4345US10584128B2Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2017·Granted Mar 10, 2020·0 cites·14 claims
- 4445US10005773B21-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 26, 2018·0 cites·29 claims
- 4545US9981963B23-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted May 29, 2018·0 cites·20 claims
- 4644US2021253568A1Azaindole derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 4741US2013012485A1Organic compoundsBAESCHLIN DANIEL KASPAR·Filed 2007·Application pending·0 cites
- 4835US2006122234A1Substituted thienyl-hydroxamic acids as histone deacetylase inhibitorsARGENTA DISCOVERY LTD·Filed 2003·Application pending·0 cites
- 4935US2009192138A1compoundsBAESCHLIN DANIEL KASPAR·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →